Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 35 peer-reviewed journal articles Updated
Critical Care Medicine · Intensive Care Unit-Acquired Weakness

What Causes Muscle Weakness & Neuropathy After Sepsis?

At a Glance

Severe muscle weakness and nerve pain after surviving sepsis is often caused by Intensive Care Unit-Acquired Weakness (ICUAW). This occurs when the severe inflammation of sepsis and life-saving ICU treatments damage muscles and nerves, requiring physical therapy and proper nutrition to recover.

If you are experiencing severe muscle weakness or nerve pain months after surviving sepsis and leaving the ICU, you are not alone. It can be profoundly frustrating and emotionally draining to survive a critical illness only to face debilitating pain and immobility. This is a very common condition broadly known as Intensive Care Unit-Acquired Weakness (ICUAW) [1]. During severe illnesses like sepsis, the immense stress on your body, combined with the life-saving treatments required in the ICU, can cause physical damage to your muscles and nerves [2][3]. This damage is the direct cause of the lingering pain, tingling, and profound weakness you feel as your body tries to recover [4].

The Two Types of Weakness: CIM and CIP

Doctors generally classify this weakness into two specific conditions, though many patients experience a combination of both [5].

  • Critical Illness Myopathy (CIM): This refers specifically to damage and wasting of the muscle tissue itself [6]. When you have sepsis, your body mounts a massive inflammatory response. This severe inflammation actually triggers your body to break down its own muscle proteins [6][7]. It also damages the mitochondria, which are the “power plants” inside your cells that give your muscles energy [8][9]. Because you were likely sedated and confined to a bed, your muscles lost the mechanical stimulation of regular movement, accelerating muscle loss [10].
  • Critical Illness Polyneuropathy (CIP): This condition involves damage to your lower motor neurons—the nerves that run out to your body to tell your muscles to move and send sensory information back to your brain [11]. In CIP, the widespread inflammation and poor blood circulation in tiny blood vessels during septic shock starve these nerves of oxygen and nutrients [12][11]. This nerve damage is usually responsible for the lingering nerve pain (neuropathy), tingling, and inability to properly activate your muscles.

Why the ICU Stay Matters

The treatments that saved your life during sepsis unfortunately contribute to these conditions. Prolonged immobility and the use of mechanical ventilators are major drivers of both muscle wasting and nerve damage [2][13]. Additionally, necessary medications given in the ICU, such as high-dose corticosteroids and neuromuscular blocking agents (paralytics), are established risk factors that further contribute to muscle and nerve injury [14][15]. The longer a patient requires these interventions, the higher the risk and severity of the resulting weakness [16].

Adults vs. Children

While this extreme weakness is highly prevalent in adults who survive the ICU, it is diagnosed much less frequently in children [17][18]. Even after experiencing severe septic shock, pediatric patients appear to develop less long-term muscle and nerve damage [19]. Researchers believe that the active growth and ongoing development of a child’s nervous and musculoskeletal systems provide protective pathways [20][21]. However, weakness in children can sometimes be underdiagnosed because standard strength tests are difficult to perform on pediatric patients [22][17]. Parents should still be aware of the possibility and monitor for physical delays.

Getting a Diagnosis

To understand whether your symptoms are caused by CIM, CIP, or both, your doctor may order specialized tests. The most common are nerve conduction studies (NCS) and electromyography (EMG) [23]. These electrodiagnostic tests measure how well your nerves send electrical signals and how your muscles respond, which helps doctors pinpoint exactly where the damage is and map out a more precise recovery timeline [24][25].

Recovery and Treatment

Understanding your specific diagnosis is important for setting expectations [4]. Patients who only have muscle damage (CIM) generally have a more favorable prognosis and a faster recovery [26]. Those who have nerve damage (CIP) often face a longer road, with recovery typically taking months to even years for full nerve regeneration [27][28].

While there are no targeted medications to instantly reverse the damage to the muscles or nerves, physical therapy and rehabilitation are the primary treatments to rebuild strength and function [29][30]. Engaging in a structured rehabilitation program is essential for retraining muscle and nerve connections [31][32]. Recovery requires a multidisciplinary approach:

  • Physical Therapy: Consistent, targeted exercise is required to rebuild what was lost [33].
  • Nutrition: Adequate protein intake and caloric support are critical for giving your body the building blocks it needs to repair muscle tissue [34][35].
  • Symptom Management: Although the underlying nerve damage takes time to heal, doctors can prescribe specific medications to help manage the severe nerve pain and tingling while you work on rehabilitation. You do not have to suffer through the pain untreated.

Common questions in this guide

What is the difference between CIM and CIP after sepsis?
Critical Illness Myopathy (CIM) involves damage and wasting of the muscle tissue itself due to severe inflammation. Critical Illness Polyneuropathy (CIP) is damage to the nerves that control your muscles, which often causes lingering nerve pain and tingling.
Why did life-saving ICU treatments cause muscle and nerve damage?
Prolonged immobility and the use of mechanical ventilators in the ICU accelerate muscle loss. Additionally, medications like high-dose corticosteroids and paralytics used to treat severe sepsis are known risk factors for nerve and muscle injury.
How do doctors diagnose the cause of my weakness after sepsis?
Doctors typically use electrodiagnostic tests like nerve conduction studies (NCS) and electromyography (EMG). These tests measure nerve signals and muscle responses to pinpoint the exact location and type of damage.
How long does it take to recover from ICU-acquired weakness?
Recovery timelines vary based on your specific diagnosis. Patients with only muscle damage often recover faster, while those with nerve damage may take months or even years for full nerve regeneration.
What are the best treatments for muscle weakness after sepsis?
Physical therapy and structured rehabilitation are the primary treatments to rebuild strength. Proper nutrition with adequate protein is also essential to help your body repair damaged muscle tissue, while doctors can prescribe medications to manage nerve pain.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms, should I have an EMG or nerve conduction study to determine if my weakness is caused by muscle damage (CIM), nerve damage (CIP), or both?
  2. 2.What are my options for managing my daily nerve pain so I can more actively and comfortably participate in physical therapy?
  3. 3.Given the specific life-saving medications I received in the ICU, such as steroids or paralytics, what is a realistic timeline for my physical recovery?
  4. 4.Are there specific physical therapy techniques or programs that are most appropriate for rebuilding my strength at this stage?
  5. 5.What specific nutritional goals, such as daily protein intake, should I aim for to help rebuild my damaged muscle tissue?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

How Does Physical Therapy Help Post-Sepsis Neuropathy?How Long Do Brain Fog & Memory Loss Last After Sepsis?How to Get an IEP for Pediatric Post-Sepsis SyndromeHow Do I Manage PTSD and Fear of Reinfection After Sepsis?What is a PICS Recovery Clinic? How to Find OneWhat Causes Chronic Pain in Post-Sepsis Syndrome?What Causes Insomnia and Sleep Disturbances After Sepsis?What is PICS-F? Managing Family Trauma After the ICUWhat Is the 50% Rule in Post-Sepsis Recovery?Is It Post-Sepsis Fatigue or a New Infection?What Records Are Needed for Post-Sepsis Follow-Up?Questions to Ask Your Doctor About Post-Sepsis SyndromeWhy Adult Sepsis Recovery Takes Longer

References

References (35)
  1. 1

    Intensive care unit-acquired weakness.

    Horn J, Hermans G

    Handbook of clinical neurology 2017; (141()):531-543 doi:10.1016/B978-0-444-63599-0.00029-6.

    PMID: 28190434
  2. 2

    [Critical illness myopathy and polyneuropathy].

    Senger D, Erbguth F

    Medizinische Klinik, Intensivmedizin und Notfallmedizin 2017; (112(7)):589-596 doi:10.1007/s00063-017-0339-0.

    PMID: 28875277
  3. 3

    Early detection of ICU-acquired weakness in septic shock patients ventilated longer than 72 h.

    Attwell C, Sauterel L, Jöhr J, et al.

    BMC pulmonary medicine 2022; (22(1)):466 doi:10.1186/s12890-022-02193-7.

    PMID: 36474276
  4. 4

    Neuromuscular Disorders in the Intensive Care Unit.

    Birch TB

    Continuum (Minneapolis, Minn.) 2021; (27(5)):1344-1364 doi:10.1212/CON.0000000000001004.

    PMID: 34618763
  5. 5

    Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

    Tankisi A, Pedersen TH, Bostock H, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(6)):1347-1357 doi:10.1016/j.clinph.2021.01.017.

    PMID: 33676846
  6. 6

    Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?

    Versace V, Sebastianelli L, Ferrazzoli D, et al.

    Frontiers in neurology 2021; (12()):625144 doi:10.3389/fneur.2021.625144.

    PMID: 33584530
  7. 7

    Endoplasmic reticulum stress promotes sepsis-induced muscle atrophy via activation of STAT3 and Smad3.

    Zheng Y, Dai H, Chen R, et al.

    Journal of cellular physiology 2023; (238(3)):582-596 doi:10.1002/jcp.30950.

    PMID: 36791253
  8. 8

    Should nutrition therapy be modified to account for mitochondrial dysfunction in critical illness?

    Flower L, Page A, Puthucheary Z

    JPEN. Journal of parenteral and enteral nutrition 2021; (45(S2)):60-65 doi:10.1002/jpen.2190.

    PMID: 34115880
  9. 9

    Parkin Overexpression Attenuates Sepsis-Induced Muscle Wasting.

    Leduc-Gaudet JP, Mayaki D, Reynaud O, et al.

    Cells 2020; (9(6)) doi:10.3390/cells9061454.

    PMID: 32545383
  10. 10

    Mechanical Signaling in the Pathophysiology of Critical Illness Myopathy.

    Kalamgi RC, Larsson L

    Frontiers in physiology 2016; (7()):23 doi:10.3389/fphys.2016.00023.

    PMID: 26869939
  11. 11

    The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

    Friedrich O, Reid MB, Van den Berghe G, et al.

    Physiological reviews 2015; (95(3)):1025-109 doi:10.1152/physrev.00028.2014.

    PMID: 26133937
  12. 12

    Increasing motor neuron excitability to treat weakness in sepsis.

    Nardelli P, Powers R, Cope TC, Rich MM

    Annals of neurology 2017; (82(6)):961-971 doi:10.1002/ana.25105.

    PMID: 29171917
  13. 13

    Critical illness-associated diaphragm weakness.

    Dres M, Goligher EC, Heunks LMA, Brochard LJ

    Intensive care medicine 2017; (43(10)):1441-1452 doi:10.1007/s00134-017-4928-4.

    PMID: 28917004
  14. 14

    Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis.

    Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ

    Critical care medicine 2016; (44(11)):2070-2078 doi:10.1097/CCM.0000000000001839.

    PMID: 27513545
  15. 15

    Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis.

    Yang T, Li Z, Jiang L, Xi X

    Critical care (London, England) 2018; (22(1)):187 doi:10.1186/s13054-018-2111-0.

    PMID: 30075789
  16. 16

    Early shoulder-girdle MRI findings in severe COVID-19-related intensive care unit-acquired weakness: a prospective cohort study.

    Daste C, Mihoubi F, Roren A, et al.

    European radiology 2023; (33(7)):4994-5006 doi:10.1007/s00330-023-09468-5.

    PMID: 36912923
  17. 17

    Intensive Care Unit-Acquired Weakness in Children: A Prospective Observational Study Using Simplified Serial Electrophysiological Testing (PEDCIMP Study).

    Kasinathan A, Sharawat IK, Singhi P, et al.

    Neurocritical care 2021; (34(3)):927-934 doi:10.1007/s12028-020-01123-x.

    PMID: 33025545
  18. 18

    Electrodiagnostic studies in the intensive care unit: A comparison study 2 decades later.

    Ojha A, Zivkovic SA, Lacomis D

    Muscle & nerve 2018; (57(5)):772-776 doi:10.1002/mus.25998.

    PMID: 29053882
  19. 19

    ICU-Acquired Weakness: A Rehabilitation Perspective of Diagnosis, Treatment, and Functional Management.

    Zorowitz RD

    Chest 2016; (150(4)):966-971 doi:10.1016/j.chest.2016.06.006.

    PMID: 27312737
  20. 20

    Life after Critical Illness in Children-Toward an Understanding of Pediatric Post-intensive Care Syndrome.

    Watson RS, Choong K, Colville G, et al.

    The Journal of pediatrics 2018; (198()):16-24 doi:10.1016/j.jpeds.2017.12.084.

    PMID: 29728304
  21. 21

    The Effect of Aging Physiology on Critical Care.

    Darden DB, Moore FA, Brakenridge SC, et al.

    Critical care clinics 2021; (37(1)):135-150 doi:10.1016/j.ccc.2020.08.006.

    PMID: 33190766
  22. 22

    Feasibility and Reliability of Muscle Strength Testing in Critically Ill Children.

    Siu K, Al-Harbi S, Clark H, et al.

    Journal of pediatric intensive care 2015; (4(4)):218-224 doi:10.1055/s-0035-1563544.

    PMID: 31110873
  23. 23

    Critical Illness Neuropathy.

    Tankisi H, de Carvalho M, Z'Graggen WJ

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2020; (37(3)):205-207 doi:10.1097/WNP.0000000000000658.

    PMID: 32358246
  24. 24

    Optimizing testing methods and collection of reference data for differentiating critical illness polyneuropathy from critical illness MYOPATHIES.

    Marrero HG, Stålberg EV

    Muscle & nerve 2016; (53(4)):555-63 doi:10.1002/mus.24886.

    PMID: 26311145
  25. 25

    Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers.

    Isfort M, McVerry BJ, Shutter L, et al.

    Muscle & nerve 2022; (66(1)):90-95 doi:10.1002/mus.27561.

    PMID: 35470438
  26. 26

    Clinical review: intensive care unit acquired weakness.

    Hermans G, Van den Berghe G

    Critical care (London, England) 2015; (19()):274 doi:10.1186/s13054-015-0993-7.

    PMID: 26242743
  27. 27

    Diagnosis of "intensive care unit-acquired weakness" and "critical illness myopathy": Do the diagnostic criteria need to be revised?

    Rodriguez B, Schefold JC, Z'Graggen WJ

    Clinical neurophysiology practice 2024; (9()):236-241 doi:10.1016/j.cnp.2024.08.002.

    PMID: 39282048
  28. 28

    New index for distinguishing between critical illness myopathy and neuromyopathy: CMAP amplitude/duration index.

    Uzunçakmak Uyanik H, Yildiz FG, Temuçin ÇM

    Turkish journal of medical sciences 2025; (55(1)):112-120 doi:10.55730/1300-0144.5949.

    PMID: 40104295
  29. 29

    Best Evidence Summary on Early Exercise for Prevention of ICU-Acquired Weakness: An Evidence-Based Synthesis.

    Bai X, Gu C, Li Y, et al.

    Journal of multidisciplinary healthcare 2026; (19()):574831 doi:10.2147/JMDH.S574831.

    PMID: 41737368
  30. 30

    From the Intensive Care Unit to Recovery: Managing Post-intensive Care Syndrome in Critically Ill Patients.

    Ekong M, Monga TS, Daher JC, et al.

    Cureus 2024; (16(5)):e61443 doi:10.7759/cureus.61443.

    PMID: 38953087
  31. 31

    Combined Effects of Early Mobilization and Nutrition on ICU-Acquired Weakness.

    Formenti P, Menozzi A, Sabbatini G, et al.

    Nutrients 2025; (17(6)) doi:10.3390/nu17061073.

    PMID: 40292494
  32. 32

    Optimal timing for early mobilization initiatives in intensive care unit patients: A systematic review and network meta-analysis.

    Ruo Yu L, Jia Jia W, Meng Tian W, et al.

    Intensive & critical care nursing 2024; (82()):103607 doi:10.1016/j.iccn.2023.103607.

    PMID: 38158250
  33. 33

    Early Mobilization Dose Reporting in Randomized Clinical Trials With Patients Who Were Mechanically Ventilated: A Scoping Review.

    González-Seguel F, Letelier-Bernal R

    Physical therapy 2024; (104(6)) doi:10.1093/ptj/pzae048.

    PMID: 38519113
  34. 34

    Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review.

    Vrettou CS, Mantziou V, Vassiliou AG, et al.

    Life (Basel, Switzerland) 2022; (12(1)) doi:10.3390/life12010107.

    PMID: 35054500
  35. 35

    Feasibility of a home-based interdisciplinary rehabilitation program for patients with Post-Intensive Care Syndrome: the REACH study.

    Major ME, Dettling-Ihnenfeldt D, Ramaekers SPJ, et al.

    Critical care (London, England) 2021; (25(1)):279 doi:10.1186/s13054-021-03709-z.

    PMID: 34353341

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or physical therapist about your specific recovery and rehabilitation plan after sepsis.

Get notified when new evidence is published on Post-Sepsis Syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.